Seung-Hyun Oh
Overview
Explore the profile of Seung-Hyun Oh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Lee H, Oh S, Kim C, Kim J, Yoo S, et al.
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598338
Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of death worldwide. Burge is widely used in East Asia for cardiovascular health, showing potential benefits...
2.
Oh S, Lee M, Lee B
Chem Pharm Bull (Tokyo)
. 2024 Oct;
72(10):845-855.
PMID: 39358209
Obesity is a global medical issue that can be effectively treated by relieving adipose inflammation and subsequent insulin resistance. Diosgenin (DIOS) has various effects as a steroidal saponin in inflammatory...
3.
Oh S, Oh M, Lee S, Kim D, Lee J, Lee S, et al.
ACS Appl Mater Interfaces
. 2023 Aug;
15(33):39614-39624.
PMID: 37556112
Bioelectronic devices that offer real-time measurements, biological signal processing, and continuous monitoring while maintaining stable performance are in high demand. The materials used in organic electrochemical transistors (OECTs) demonstrate high...
4.
Lee S, Cho Y, Lee J, Jung Y, Oh S, Sun J, et al.
Adv Sci (Weinh)
. 2021 May;
8(10):2001544.
PMID: 34026425
Organic neuromorphic computing/sensing platforms are a promising concept for local monitoring and processing of biological signals in real time. Neuromorphic devices and sensors with low conductance for low power consumption...
5.
Oh S, Kim W, Kim J, Younes M, El-Naggar A, Myers J, et al.
Clin Cancer Res
. 2019 Aug;
25(15):4861.
PMID: 31371311
No abstract available.
6.
Kim J, Lee G, Kim H, Jo Y, Hong S, Lee J, et al.
Free Radic Biol Med
. 2016 Nov;
101:384-392.
PMID: 27825965
Cancer cells have been suggested to be more susceptible to oxidative damages and highly dependent on antioxidant capacity in comparison with normal cells, and thus targeting antioxidant enzymes has been...
7.
Lee J, Kang J, Boo H, Hwang S, Hong S, Lee S, et al.
Nat Commun
. 2015 Oct;
6:8499.
PMID: 26465273
Drug resistance is a major impediment in medical oncology. Recent studies have emphasized the importance of the tumour microenvironment (TME) to innate resistance, to molecularly targeted therapies. In this study,...
8.
Cho M, Park J, Choi H, Park M, Won H, Park Y, et al.
Nat Commun
. 2015 Jul;
6:7821.
PMID: 26199140
DOT1L has emerged as an anticancer target for MLL-associated leukaemias; however, its functional role in solid tumours is largely unknown. Here we identify that DOT1L cooperates with c-Myc and p300...
9.
Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al.
Mol Cancer
. 2015 Jun;
14:113.
PMID: 26041671
Background: Therapeutic interventions in the insulin-like growth factor receptor (IGF-1R) pathway were expected to provide clinical benefits; however, IGF-1R tyrosine kinase inhibitors (TKIs) have shown limited antitumor efficacy, and the...
10.
Lee J, Won H, Park J, Kim H, Choi H, Shin D, et al.
J Clin Invest
. 2015 Mar;
125(5):1801-14.
PMID: 25822021
The polycomb protein MEL-18 has been proposed as a tumor suppressor in breast cancer; however, its functional relevance to the hormonal regulation of breast cancer remains unknown. Here, we demonstrated...